Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cain International is a privately held investment firm that operates across the real estate and business investment sectors. While not a traditional biotechnology or pharmaceutical developer, the firm is a significant player in the healthcare and life sciences ecosystem through its extensive investments in life science real estate and wellness-focused businesses. Cain International specializes in providing debt and equity capital for the development of state-of-the-art laboratory spaces and research facilities in major global hubs, including London and the United States. Their portfolio includes high-profile life science developments designed to support the growth of emerging and established biotech companies. Additionally, the firm invests in lifestyle and wellness brands that intersect with the broader healthcare and preventative medicine markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cain International.